12.47 USD
+0.2 (+1.63%)
At close: Jan 30, 2026
12.5 USD
+0.03 (+0.24%)
After Hours: 1/30/2026, 8:25:07 PM
Taking everything into account, XRAY scores 4 out of 10 in our fundamental rating. XRAY was compared to 186 industry peers in the Health Care Equipment & Supplies industry. XRAY has a medium profitability rating, but doesn't score so well on its financial health evaluation. XRAY has a bad growth rate and is valued cheaply. XRAY also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
- XRAY had positive earnings in the past year.
- In the past year XRAY had a positive cash flow from operations.
- In the past 5 years XRAY reported 4 times negative net income.
- Each year in the past 5 years XRAY had a positive operating cash flow.
1.2 Ratios
- XRAY has a Return On Assets (-15.60%) which is in line with its industry peers.
- XRAY has a Return On Equity (-59.68%) which is comparable to the rest of the industry.
- The Return On Invested Capital of XRAY (5.04%) is better than 76.22% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for XRAY is below the industry average of 8.81%.
- The 3 year average ROIC (4.11%) for XRAY is below the current ROIC(5.04%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.6% | ||
| ROE | -59.68% | ||
| ROIC | 5.04% |
ROA(3y)-10.01%
ROA(5y)-5.27%
ROE(3y)-25.27%
ROE(5y)-13.81%
ROIC(3y)4.11%
ROIC(5y)4.26%
1.3 Margins
- XRAY has a Operating Margin of 7.48%. This is in the better half of the industry: XRAY outperforms 74.59% of its industry peers.
- In the last couple of years the Operating Margin of XRAY has declined.
- XRAY has a Gross Margin (51.10%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of XRAY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.48% | ||
| PM (TTM) | N/A | ||
| GM | 51.1% |
OM growth 3Y-25.8%
OM growth 5Y-12.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.16%
GM growth 5Y-0.95%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XRAY is destroying value.
- Compared to 1 year ago, XRAY has less shares outstanding
- The number of shares outstanding for XRAY has been reduced compared to 5 years ago.
- Compared to 1 year ago, XRAY has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.96, we must say that XRAY is in the distress zone and has some risk of bankruptcy.
- XRAY has a Altman-Z score (0.96) which is comparable to the rest of the industry.
- The Debt to FCF ratio of XRAY is 29.94, which is on the high side as it means it would take XRAY, 29.94 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 29.94, XRAY is doing good in the industry, outperforming 68.11% of the companies in the same industry.
- A Debt/Equity ratio of 1.36 is on the high side and indicates that XRAY has dependencies on debt financing.
- XRAY has a Debt to Equity ratio of 1.36. This is in the lower half of the industry: XRAY underperforms 77.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 29.94 | ||
| Altman-Z | 0.96 |
ROIC/WACC0.55
WACC9.11%
2.3 Liquidity
- XRAY has a Current Ratio of 1.47. This is a normal value and indicates that XRAY is financially healthy and should not expect problems in meeting its short term obligations.
- XRAY's Current ratio of 1.47 is on the low side compared to the rest of the industry. XRAY is outperformed by 74.59% of its industry peers.
- XRAY has a Quick Ratio of 1.47. This is a bad value and indicates that XRAY is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.99, XRAY is not doing good in the industry: 74.59% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.47 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
- XRAY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.59%.
- XRAY shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.38% yearly.
- Looking at the last year, XRAY shows a decrease in Revenue. The Revenue has decreased by -7.08% in the last year.
- Measured over the past years, XRAY shows a decrease in Revenue. The Revenue has been decreasing by -1.17% on average per year.
EPS 1Y (TTM)-14.59%
EPS 3Y-16.51%
EPS 5Y-7.38%
EPS Q2Q%-26%
Revenue 1Y (TTM)-7.08%
Revenue growth 3Y-3.58%
Revenue growth 5Y-1.17%
Sales Q2Q%-4.94%
3.2 Future
- XRAY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.40% yearly.
- The Revenue is expected to grow by 1.34% on average over the next years.
EPS Next Y-1.98%
EPS Next 2Y-2.65%
EPS Next 3Y2.27%
EPS Next 5Y7.4%
Revenue Next Year-4.27%
Revenue Next 2Y-1.79%
Revenue Next 3Y-0.41%
Revenue Next 5Y1.34%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 7.89, the valuation of XRAY can be described as very cheap.
- Compared to the rest of the industry, the Price/Earnings ratio of XRAY indicates a rather cheap valuation: XRAY is cheaper than 96.76% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.32. XRAY is valued rather cheaply when compared to this.
- Based on the Price/Forward Earnings ratio of 7.88, the valuation of XRAY can be described as very cheap.
- XRAY's Price/Forward Earnings ratio is rather cheap when compared to the industry. XRAY is cheaper than 97.30% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.57, XRAY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.89 | ||
| Fwd PE | 7.88 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XRAY indicates a rather cheap valuation: XRAY is cheaper than 96.76% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, XRAY is valued a bit cheaper than 78.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.1 | ||
| EV/EBITDA | 7.31 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.65%
EPS Next 3Y2.27%
5. Dividend
5.1 Amount
- XRAY has a Yearly Dividend Yield of 5.17%, which is a nice return.
- Compared to an average industry Dividend Yield of 0.21, XRAY pays a better dividend. On top of this XRAY pays more dividend than 99.46% of the companies listed in the same industry.
- XRAY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.17% |
5.2 History
- On average, the dividend of XRAY grows each year by 11.21%, which is quite nice.
- XRAY has been paying a dividend for at least 10 years, so it has a reliable track record.
- XRAY has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.21%
Div Incr Years6
Div Non Decr Years30
5.3 Sustainability
- The earnings of XRAY are negative and hence is the payout ratio. XRAY will probably not be able to sustain this dividend level.
- The dividend of XRAY is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-14.4%
EPS Next 2Y-2.65%
EPS Next 3Y2.27%
DENTSPLY SIRONA INC / XRAY FAQ
What is the ChartMill fundamental rating of DENTSPLY SIRONA INC (XRAY) stock?
ChartMill assigns a fundamental rating of 4 / 10 to XRAY.
What is the valuation status for XRAY stock?
ChartMill assigns a valuation rating of 7 / 10 to DENTSPLY SIRONA INC (XRAY). This can be considered as Undervalued.
How profitable is DENTSPLY SIRONA INC (XRAY) stock?
DENTSPLY SIRONA INC (XRAY) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for XRAY stock?
The Price/Earnings (PE) ratio for DENTSPLY SIRONA INC (XRAY) is 7.89 and the Price/Book (PB) ratio is 1.68.
Can you provide the dividend sustainability for XRAY stock?
The dividend rating of DENTSPLY SIRONA INC (XRAY) is 7 / 10 and the dividend payout ratio is -14.4%.